JoVE Logo

Anmelden

5.6 : Phase I Reactions: Hydrolytic Reactions

Hydrolysis, a cornerstone of phase I biotransformation reactions, uses water to cleave chemical bonds. This process is pivotal in drug metabolism, generating more polar metabolites that can be easily excreted.

An important hydrolytic reaction is ester hydrolysis. Ester bonds, often found in prodrugs, are broken down, increasing the solubility of drugs like aspirin and lidocaine for more straightforward elimination. Amide hydrolysis is another critical reaction, targeting amide bonds prevalent in numerous drugs. Secondary amides like acetaminophen and tertiary amides like lidocaine undergo hydrolysis, resulting in corresponding carboxylic acids and amines. Hydrazides like isoniazid also experience hydrolysis, yielding carboxylic acid and hydrazine.

Nonaromatic heterocycles, including imidazoles and pyrazoles, can also be hydrolyzed. For instance, metronidazole transforms into the respective carboxylic acid and alcohol through hydrolysis. Hydrolytic dehalogenation, removing a halogen atom from a molecule, represents another hydrolytic mechanism. Chloramphenicol, for example, can be hydrolyzed into its corresponding carboxylic acid and alcohol. Miscellaneous hydrolytic reactions extend to the hydrolysis of thioesters like captopril, which transforms into the respective carboxylic acid and thiol.

Hydrolysis significantly contributes to phase I biotransformation reactions in drug metabolism. The process enhances the polarity and solubility of metabolites, facilitating their excretion and playing an indispensable role in drug elimination.

Tags

Phase I ReactionsHydrolytic ReactionsHydrolysisDrug MetabolismEster HydrolysisAmide HydrolysisCarboxylic AcidsAcetaminophenLidocaineHydrazidesMetronidazoleHydrolytic DehalogenationChloramphenicolThioestersDrug Elimination

Aus Kapitel 5:

article

Now Playing

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

78 Ansichten

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

387 Ansichten

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

244 Ansichten

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

149 Ansichten

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

68 Ansichten

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

181 Ansichten

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

166 Ansichten

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

305 Ansichten

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

180 Ansichten

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

153 Ansichten

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

188 Ansichten

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

143 Ansichten

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

47 Ansichten

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

191 Ansichten

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

116 Ansichten

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten